AKT Is Highly Phosphorylated in Pheochromocytomas But Not in Benign Adrenocortical Tumors | Zendy

Martin Faßnacht | Zendy; Dirk Weismann | Zendy; Silke Ebert | Zendy; Patrick Adam | Zendy; Martina Zink | Zendy; Felix Beuschlein | Zendy; Stefanie Hahner | Zendy; Bruno Allolio | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

AKT Is Highly Phosphorylated in Pheochromocytomas But Not in Benign Adrenocortical Tumors

Author(s) -

Martin Faßnacht,

Dirk Weismann,

Silke Ebert,

Patrick Adam,

Martina Zink,

Felix Beuschlein,

Stefanie Hahner,

Bruno Allolio

Publication year - 2005

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2004-2198

Subject(s) - protein kinase b , pten , adrenocortical carcinoma , endocrinology , context (archaeology) , medicine , phosphorylation , pheochromocytoma , cancer research , biology , pi3k/akt/mtor pathway , signal transduction , microbiology and biotechnology , paleontology

Activation of AKT plays a major role in a variety of human neoplasias. In mice, a heterozygous deletion of the Pten gene is associated with increased activation of AKT and with development of pheochromocytomas.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research